CICLOFILIN PHARMACEUTICALS
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and degenerative diseases. Ciclofilin Pharmaceuticals Inc. is comprised of a team of business, medical, and scientific professionals with decades of experience in pharmaceutical development. Our expertise in cyclosporins, the biopharmaceutic backbone of cyclophilin inhibitors, ideally positions Ciclofilin Pharmaceuticals to develop superior medications in this emerging drug class. Our head office is located in San Diego, California, with a R&D facility in Edmonton, Alberta.
CICLOFILIN PHARMACEUTICALS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ciclofilin.com
Total Employee:
1+
Status:
Active
Contact:
17809095041
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon ASP.NET IIS ASP.NET 4.0 IIS 7 NameBright
Official Site Inspections
http://www.ciclofilin.com
- Host name: ec2-3-19-116-195.us-east-2.compute.amazonaws.com
- IP address: 3.19.116.195
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Ciclofilin Pharmaceuticals"
Ciclofilin Pharmaceuticals Corp - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ciclofilin Pharmaceuticals Corp of Edmonton, AB. Get the latest business insights from Dun & Bradstreet.See details»
Company Information - RocketReach
A biopharmaceutical company specializing in development of cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and degenerative diseases. Our Focus: Many âŚSee details»
Ciclofilin Pharmaceuticals Inc - Company Profile and News
Company profile page for Ciclofilin Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Ciclofilin Pharmaceuticals acquired by Hepion Pharmaceuticals
Ciclofilin Pharmaceuticals Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors. Acquiring Organization: Hepion Pharmaceuticals âŚSee details»
Ciclofilin Pharmaceuticals - Crunchbase
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors.See details»
Ciclofilin Pharmaceuticals - Products, Competitors, Financials ...
Headquarters Location. 12707 High Bluff Drive Suite 201. San Diego, California, 92130, United States. 619-701-5374See details»
Ciclofilin Pharmaceuticals Inc. in San Diego, California - EIN TaxId
Ciclofilin Pharmaceuticals Inc. is a corporation in San Diego, California. The employer identification number (EIN) for Ciclofilin Pharmaceuticals Inc. is 320434188. EIN for âŚSee details»
Ciclofilin Pharmaceuticals-Ciclofilin Pharmaceuticals Inc.-äźä¸čŻŚć ...
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and âŚSee details»
Ciclofilin Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical ...
Aug 14, 2023 Explore Ciclofilin Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Ciclofilin Pharmaceuticals - Company Profile - Tracxn
Ciclofilin Pharmaceuticals - US-based, preclinical stage biotech developing cyclophilin-inhibitors for infectious, inflammatory, and degenerative diseases. Acquired by ContraVir. Acquired by âŚSee details»
Ciclofilin Pharmaceuticals - PitchBook
Ciclofilin Pharmaceuticals was acquired on 10-Jun-2016. Who acquired Ciclofilin Pharmaceuticals? Ciclofilin Pharmaceuticals was acquired by Hepion Pharmaceuticals. Data âŚSee details»
ContraVir Pharmaceuticals, Inc. completed the acquisition of âŚ
Jun 9, 2016 ContraVir Pharmaceuticals, Inc. (NasdaqCM:CTRV) signed a definitive agreement to acquire Ciclofilin Pharmaceuticals Inc. on May 26, 2016. Under the terms of the merger âŚSee details»
Press Release Distribution and Management - GlobeNewswire
SAN DIEGO, April 19, 2016 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a privately held biotech, announced today that it will discuss important new âŚSee details»
Ciclofilin Pharmaceuticals - CB Insights
Explore {Ciclofilin Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Ciclofilin âŚSee details»
Ciclofilin Pharmaceuticals - Updates, News, Events, Signals
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors.See details»
Ciclofilin Pharmaceuticals Announces Formation of - GlobeNewswire
SAN DIEGO, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. (See details»
ContraVir expands hep B portfolio with Ciclofilin acquisition
May 31, 2016 Once the merger has been formally signed and sealed, Ciclofilin's founder and CEO Robert Foster will join ContraVir in the role of CSO, and will continue leading the âŚSee details»
ContraVir Pharma (CTRV) Enters Merger Agreement with Ciclofilin âŚ
May 31, 2016 Robert Foster, Pharm.D., Ph.D., Founder and CEO of Ciclofilin, commented, "CPI-431-32 is positioned to be the leading non-immunosuppressive cyclophilin inhibitor antiviral for âŚSee details»
Cyclophilin A: Promising New Target in Cardiovascular Therapy
Cyclophilin A (CyPA) has been studied as a multifunctional protein that is upregulated in a variety of inflammatory conditions, such as rheumatoid arthritis, autoimmune disease, and cancer. ...See details»